GWM
IBB icon

Geneos Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Geneos Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.8K Sell
348
-114
-25% -$19.5K ﹤0.01% 1359
2025
Q4 		$78K Sell
462
-186
-29% -$30.2K ﹤0.01% 1237
2025
Q3 		$93.6K Hold
648
– – ﹤0.01% 1147
2025
Q2 		$82K Sell
648
-1,098
-63% -$135K ﹤0.01% 1330
2025
Q1 		$223K Buy
1,746
+873
+100% +$118K ﹤0.01% 1184
2024
Q4 		$115K Buy
873
+300
+52% +$42.2K ﹤0.01% 1013
2024
Q3 		$83.5K Sell
573
-81
-12% -$11.7K ﹤0.01% 1017
2024
Q2 		$89.8K Sell
654
-292
-31% -$39K ﹤0.01% 897
2024
Q1 		$130K Buy
946
+502
+113% +$68.6K 0.01% 795
2023
Q4 		$60.3K Sell
444
-200
-31% -$24.4K ﹤0.01% 1006
2023
Q3 		$78.8K Buy
644
+92
+17% +$11.7K ﹤0.01% 940
2023
Q2 		$70.1K Hold
552
– – ﹤0.01% 979
2023
Q1 		$71.3K Sell
552
-41
-7% -$5.37K ﹤0.01% 959
2022
Q4 		$77.9K Buy
593
+63
+12% +$8.14K ﹤0.01% 899
2022
Q3 		$61K Sell
530
-709
-57% -$88K ﹤0.01% 960
2022
Q2 		$148K Buy
1,239
+27
+2% +$3.21K 0.01% 859
2022
Q1 		$157K Sell
1,212
-921
-43% -$120K 0.01% 904
2021
Q4 		$325K Sell
2,133
-261
-11% -$40.4K 0.01% 706
2021
Q3 		$380K Sell
2,394
-47
-2% -$7.91K 0.01% 647
2021
Q2 		$402K Sell
2,441
-270
-10% -$41.6K 0.02% 619
2021
Q1 		$419K Sell
2,711
-1,568
-37% -$249K 0.01% 679
2020
Q4 		$487K Sell
4,279
-5,192
-55% -$742K 0.02% 547
2020
Q3 		$1.26M Buy
9,471
+7,226
+322% +$980K 0.07% 257
2020
Q2 		$303K Buy
2,245
+186
+9% +$23.7K 0.02% 547
2020
Q1 		$224K Buy
2,059
+11
+0.5% +$1.27K 0.02% 578
2019
Q4 		$249K Buy
2,048
+266
+15% +$29.7K 0.01% 615
2019
Q3 		$177K Sell
1,782
-3,603
-67% -$377K 0.01% 696
2019
Q2 		$587K Buy
5,385
+52
+1% +$5.53K 0.04% 372
2019
Q1 		$596K Buy
5,333
+374
+8% +$41K 0.04% 358
2018
Q4 		$470K Buy
4,959
+761
+18% +$80.8K 0.03% 390
2018
Q3 		$511K Buy
4,198
+128
+3% +$15.1K 0.03% 383
2018
Q2 		$447K Sell
4,070
-1,245
-23% -$133K 0.03% 344
2018
Q1 		$567K Sell
5,315
-504
-9% -$55.9K 0.05% 281
2017
Q4 		$621K Sell
5,819
-13,678
-70% -$1.46M 0.06% 279
2017
Q3 		$2.16M Buy
19,497
+906
+5% +$96.8K 0.21% 120
2017
Q2 		$1.92M Buy
18,591
+618
+3% +$60.9K 0.2% 118
2017
Q1 		$1.8M Buy
17,973
+13,455
+298% +$1.29M 0.19% 120
2016
Q4 		$399K Sell
4,518
-93
-2% -$8.46K 0.05% 300
2016
Q3 		$444K Buy
4,611
+411
+10% +$39.1K 0.06% 266
2016
Q2 		$367K Buy
4,200
+225
+6% +$20.2K 0.05% 307
2016
Q1 		$355K Buy
+3,975
New +$355K 0.05% 303

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geneos Wealth Management's IBB Position: Q1 2026 in Review

Geneos Wealth Management reduced its iShares Biotechnology ETF (IBB) stake by 25% in Q1 2026, selling an estimated $19.5K and leaving 348 shares worth $58.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1359.

Geneos Wealth Management first reported a position in IBB in Q1 2016 and has held it in 41 quarters since. The position peaked at $2.16M in Q3 2017. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Geneos Wealth Management held 348 shares of iShares Biotechnology ETF worth $58.8K as of Q1 2026.
  • Geneos Wealth Management sold 114 iShares Biotechnology ETF shares in Q1 2026, an estimated $19.5K.
  • iShares Biotechnology ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1359 holding.
  • Geneos Wealth Management first reported a position in iShares Biotechnology ETF in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's iShares Biotechnology ETF position peaked at $2.16M in Q3 2017.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.